Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Vescini

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Journal of Nephrology|May 28, 2003
Bone mass loss in calcium stone disease: focus on hypercalciuria and metabolic factorsRenata Caudarella, Fabio Vescini, Angela Buffa, et al.
International Journal of Molecular Sciences|January 7, 2021
Energy Metabolism and Ketogenic Diets: What about the Skeletal Health? A Narrative Review and a Prospective Vision for Planning Clinical Trials on this IssueDaniela Merlotti, Roberta Cosso, Cristina Eller-Vainicher, et al.
Reviews in Endocrine & Metabolic Disorders|October 24, 2019
Calcium citrate: from biochemistry and physiology to clinical applicationsAndrea Palermo, Anda Mihaela Naciu, Gaia Tabacco, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|July 15, 2020
A Retrospective Cohort Study of Histology-Proven Neuroendocrine Neoplasms in the Italian Area of UdineFrancesca Valent, Annarita Tullio, Elda Kara, et al.
Journal of Clinical Medicine|April 3, 2021
The Impact of Antiosteoporotic Drugs on Glucose Metabolism and Fracture Risk in Diabetes: Good or Bad News?Athanasios D Anastasilakis, Elena Tsourdi, Gaia Tabacco, et al.
Minerva Endocrinology|November 27, 2025
Efficacy and safety of oral semaglutide as add-on therapy in poorly controlled type 2 diabetes on background SGLT2 inhibitors: a real-world, multi-center, retrospective, observational study (RYS2)Maria E Malighetti, Fabio Vescini, Maria Carpentieri, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|December 22, 2018
An Unusual Case of Medullary Thyroid Carcinoma and A Revision of Current LiteratureClaudia Cipri, Fabio Vescini, Francesca Torresan, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|July 1, 2020
Selenium: A Trace Element for a Healthy Skeleton - A Narrative ReviewFabio Vescini, Iacopo Chiodini, Andrea Palermo, et al.
Clinical Endocrinology|April 1, 2025
Application of Calcaneal Ultrasonography for Long-Term Fracture Risk Assessment in Diabetic OsteopathyAntonio Stefano Salcuni, Alessandro Brunetti, Francesca Marchese, et al.
European Journal of Endocrinology|May 3, 2019
DIAGNOSIS OF ENDOCRINE DISEASE: Evaluation of bone fragility in endocrine disordersCristina Eller-Vainicher, Alberto Falchetti, Luigi Gennari, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Journal of Nephrology|May 28, 2003
Bone mass loss in calcium stone disease: focus on hypercalciuria and metabolic factorsRenata Caudarella, Fabio Vescini, Angela Buffa, et al.
International Journal of Molecular Sciences|January 7, 2021
Energy Metabolism and Ketogenic Diets: What about the Skeletal Health? A Narrative Review and a Prospective Vision for Planning Clinical Trials on this IssueDaniela Merlotti, Roberta Cosso, Cristina Eller-Vainicher, et al.
Reviews in Endocrine & Metabolic Disorders|October 24, 2019
Calcium citrate: from biochemistry and physiology to clinical applicationsAndrea Palermo, Anda Mihaela Naciu, Gaia Tabacco, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|July 15, 2020
A Retrospective Cohort Study of Histology-Proven Neuroendocrine Neoplasms in the Italian Area of UdineFrancesca Valent, Annarita Tullio, Elda Kara, et al.
Journal of Clinical Medicine|April 3, 2021
The Impact of Antiosteoporotic Drugs on Glucose Metabolism and Fracture Risk in Diabetes: Good or Bad News?Athanasios D Anastasilakis, Elena Tsourdi, Gaia Tabacco, et al.
Minerva Endocrinology|November 27, 2025
Efficacy and safety of oral semaglutide as add-on therapy in poorly controlled type 2 diabetes on background SGLT2 inhibitors: a real-world, multi-center, retrospective, observational study (RYS2)Maria E Malighetti, Fabio Vescini, Maria Carpentieri, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|December 22, 2018
An Unusual Case of Medullary Thyroid Carcinoma and A Revision of Current LiteratureClaudia Cipri, Fabio Vescini, Francesca Torresan, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|July 1, 2020
Selenium: A Trace Element for a Healthy Skeleton - A Narrative ReviewFabio Vescini, Iacopo Chiodini, Andrea Palermo, et al.
Clinical Endocrinology|April 1, 2025
Application of Calcaneal Ultrasonography for Long-Term Fracture Risk Assessment in Diabetic OsteopathyAntonio Stefano Salcuni, Alessandro Brunetti, Francesca Marchese, et al.
European Journal of Endocrinology|May 3, 2019
DIAGNOSIS OF ENDOCRINE DISEASE: Evaluation of bone fragility in endocrine disordersCristina Eller-Vainicher, Alberto Falchetti, Luigi Gennari, et al.
Pageof 6